1. Executive Summary 2. Global Vaccines Market Size & Forecast (2015 – 2025) 3. Market Share Analysis of Global Vaccines Market (%) 3.1 Global Vaccines Market Share, By Disease 3.2 Global Vaccines Market Share, By End User 3.3 Global Vaccines Market Share, By Leading Vaccine 3.4 Global Vaccines Market Share, By Company 4. Global Vaccines Market – Key Market Dynamics 4.1 Key Market Drivers 4.2 Key Market Inhibitors 5. Global Vaccines Market, By Disease 5.1 Pneumococcal Disease 5.2 Diphtheria, Tetanus and Pertussis (DTP) 5.3 Influenza 5.4 Human Papilloma Virus (HPV) 5.5 Meningococcal 5.6 Hepatitis 5.7 Measles, Mumps, and Rubella (MMR) 5.8 Rotavirus 5.9 Varicella 5.10 Other Diseases 6. Global Vaccines Market, By End User 6.1 Pediatric Vaccines 6.2 Adult Vaccines 7. Global Vaccines Market, By Leading Vaccine 7.1 Prevnar / Prevnar 13 7.2 Gardasil / Gardasil 9 7.3 Vaxigrip 7.4 Fluzone 7.5 Flublok 7.6 Varivax 7.7 Menactra 7.8 Proquad 7.9 Pneumovax 23 7.10 Fluarix/FluLaval 7.11 Havrix/Twinrix/Engerix–B 7.12 Priorix, Priorix Tetra, Varilrix 7.13 M–M–R II 7.14 Adacel 7.15 Boostrix 7.16 Bexsero 7.17 Menveo 7.18 Cervarix 7.19 Trumenba 7.20 Shingrix 7.21 Pentacel, Pentaxim, Imovax, Hexaxim 7.22 Rotateq 7.23 Zostavax 7.24 Rotarix 7.25 Synflorix 7.26 Pediarix,Infanrix 7.27 Ticovac 7.28 Biken Ha 7.29 Tetrabik 7.30 Mearubik 7.31 Varicella (MTP) 7.32 Jebik V 7.33 Flumist/Fluenz 7.34 BioThrax 7.35 Dukoral 7.36 Ixiaro 7.37 InLive 7.38 HeaLive 7.39 BiLive 7.40 Anflu 7.41 EasySix 7.42 Imvamune 7.43 Other Vaccines 8. Major Deals and Agreement Happenings in the Global Vaccines Market 8.1 Merger & Acquisitions 8.2 Collaboration Deal 8.3 Licensing Agreement 8.4 Exclusive Agreement 8.5 Distribution Agreement 8.6 Partnerships 9. Key Players in the Global Vaccines Market 9.1 Sanofi Pasteur 9.1.1 Business Overview 9.1.2 Vaccines Portfolio 9.1.3 Vaccines Market Value Analysis & Forecast 9.1.4 Promising Vaccines in the Clinical Development 9.1.5 Recent Development 9.2 GlaxoSmithKline (GSK) 9.2.1 Business Overview 9.2.2 Vaccines Portfolio 9.2.3 Vaccines Market Value Analysis & Forecast 9.2.4 Promising Vaccines in the Clinical Development 9.2.5 Recent Development 9.3 Merck 9.3.1 Business Overview 9.3.2 Vaccines Portfolio 9.3.3 Vaccines Market Value Analysis & Forecast 9.3.4 Promising Vaccines in the Clinical Development 9.3.5 Recent Development 9.4 Pfizer 9.4.1 Business Overview 9.4.2 Vaccines Portfolio 9.4.3 Vaccines Market Value Analysis & Forecast 9.4.4 Promising Vaccines in the Clinical Development 9.4.5 Recent Development 9.5 AstraZeneca 9.5.1 Business Overview 9.5.2 Vaccines Portfolio 9.5.3 Vaccines Market Value Analysis & Forecast 9.5.4 Recent Development 9.6 Mitsubishi Tanabe Pharma 9.6.1 Business Overview 9.6.2 Vaccines Portfolio 9.6.3 Vaccine Market Value Analysis & Forecast 9.6.4 Promising Vaccines in the Clinical Development 9.6.5 Recent Development 9.7 Emergent BioSolutions 9.7.1 Business Overview 9.7.2 Vaccines Portfolio 9.7.3 Vaccine Market Value Analysis & Forecast 9.7.4 Promising Vaccines in the Clinical Development 9.7.5 Recent Development 9.8 Astlellas Pharma Inc 9.8.1 Business Overview 9.8.2 Vaccines Portfolio 9.8.3 Vaccines Market Value Analysis & Forecast 9.8.4 Recent Development 9.9 Valneva 9.9.1 Business Overview 9.9.2 Vaccines Portfolio 9.9.3 Vaccines Market Value Analysis & Forecast 9.9.4 Promising Vaccines in the Clinical Development 9.9.5 Recent Development 9.10 Seqirus 9.10.1 Business Overview 9.10.2 Vaccines Portfolio 9.10.3 Vaccine Market Value Analysis & Forecast 9.10.4 Promising Vaccines in the Clinical Development 9.10.5 Recent Development 9.11 Bavarian Nordic 9.11.1 Business Overview 9.11.2 Vaccines Portfolio 9.11.3 Vaccine Market Value Analysis & Forecast 9.11.4 Promising Vaccines in the Clinical Development 9.11.5 Recent Development 9.12 Sinovac 9.12.1 Business Overview 9.12.2 Vaccines Portfolio 9.12.3 Vaccine Market Value Analysis & Forecast 9.12.4 Promising Vaccines in the Clinical Development 9.12.5 Recent Development 9.13 Panacea Biotec 9.13.1 Business Overview 9.13.2 Vaccines Portfolio 9.13.3 Vaccine Market Value Analysis & Forecast 9.13.4 Promising Vaccines in the Clinical Development 9.13.5 Recent Development 9.14 Bharat Biotech 9.14.1 Business Overview 9.14.2 Vaccines Portfolio 9.14.3 Promising Vaccines in the Clinical Development 9.14.4 Recent Development 9.15 Serum Institute of India 9.15.1 Business Overview 9.15.2 Vaccines Portfolio 9.15.3 Promising Vaccines in Clinical Development 9.15.4 Recent Development 9.16 Biological E. Limited 9.16.1 Business Overview 9.16.2 Vaccines Portfolio 9.16.3 Promising Vaccines in Clinical Development 9.16.4 Recent Development 10. Emerging Players in the Global Vaccines Market 10.1 Vaccitech 10.1.1 Business Overview 10.1.2 Promising Vaccines in the Clinical Development 10.1.3 Recent Development 10.2 Janssen (Johnson& Johnson) 10.2.1 Business Overview 10.2.2 Promising Vaccines in the Clinical Development 10.2.3 Recent Development 10.3 Novavax 10.3.1 Business Overview 10.3.2 Promising Vaccines in the Clinical Development 10.3.3 Recent Development 10.4 VBI Vaccines 10.4.1 Business Overview 10.4.2 Promising Vaccines in the Clinical Development 10.4.3 Recent Development 10.5 GeoVax 10.5.1 Business Overview 10.5.2 Promising Vaccines in the Clinical Development 10.5.3 Recent Development 10.6 Moderna Inc 10.6.1 Business Overview 10.6.2 Promising Vaccines in the Clinical Development 10.6.3 Recent Development 10.7 Biondvax 10.7.1 Business Overview 10.7.2 Promising Vaccines in the Clinical Development 10.7.3 Recent Development 10.8 Integrated Biotherapeutics Inc 10.8.1 Business Overview 10.8.2 Promising Vaccines in the Clinical Development 10.8.3 Recent Development 10.9 GeneOne Life Science 10.9.1 Business Overview 10.9.2 Promising Vaccines in the Clinical Development 10.9.3 Recent Development 10.10 Profectus BioSciences 10.10.1 Business Overview 10.10.2 Promising Vaccines in the Clinical Development 10.10.3 Recent Development 10.11 Pneumagen 10.11.1 Business Overview 10.11.2 Promising Vaccines in the Clinical Development 10.11.3 Recent Development 10.12 Themis Bioscience 10.12.1 Business Overview 10.12.2 Promising Vaccines in the Clinical Development 10.12.3 Recent Development 10.13 Xeme Biopharma Inc 10.13.1 Business Overview 10.13.2 Promising Vaccines in the Clinical Development 10.13.3 Recent Development 10.14 Altimmune 10.14.1 Business Overview 10.14.2 Promising Vaccines in the Clinical Development 10.14.3 Recent Development 10.15 Pfenex Inc 10.15.1 Business Overview 10.15.2 Promising Vaccines in the Clinical Development 10.15.3 Recent Development 10.16 Northwest Biotherapeutics 10.16.1 Business Overview 10.16.2 Promising Vaccines in the Clinical Development 10.16.3 Recent Development 10.17 OncBioMune Pharmaceuticals 10.17.1 Business Overview 10.17.2 Promising Vaccines in the Clinical Development 10.17.3 Recent Development

List of Tables: Table 9–1: Merger & Acquisitions in the Global Vaccines Market Table 9–2: Collaboration Deal in the Global Vaccines Market Table 9–3: Licensing Agreement in the Global Vaccines Market Table 9–4: Exclusive Agreement in the Global Vaccines Market Table 9–5: Distribution Agreement in the Global Vaccines Market Table 9–6: Partnerships in the Global Vaccines Market Table 10–1: Sanofi Promising Vaccines in the Clinical Development Table 10–2: GSK Promising Vaccines in the Clinical Development Table 10–3: Merck Promising Vaccines in the Clinical Development Table 10–4: Pfizer Promising Vaccines in the Clinical Development Table 10–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development Table 10–6: Emergent Biosolutions Promising Vaccines in the Clinical Development Table 10–7: Valneva Promising Vaccines in the Clinical Development Table 10–8: Seqirus Promising Vaccines in the Clinical Development Table 10–9: Bavarian Nordic Promising Vaccines in the Clinical Development Table 10–10: Sinovac Promising Vaccines in the Clinical Development Table 10–11: Panacea Biotec Promising Vaccines in the Clinical Development Table 10–12: Bharat Biotech Promising Vaccines in the Clinical Development Table 11–1: Vaccitech Promising Vaccines in the Clinical Development Table 11–2: Janssen Promising Vaccines in the Clinical Development Table 11–3: Novavax Promising Vaccines in the Clinical Development Table 11–4: VBI Vaccines Promising Vaccines in the Clinical Development Table 11–5: GeoVax Promising Vaccines in the Clinical Development Table 11–6: Moderna Promising Vaccines in the Clinical Development Table 11–7: Biondvax Promising Vaccines in the Clinical Development Table 11–8: Integrated Biotherapeutics Promising Vaccines in the Clinical Development Table 11–9: GeneOne Life Science Promising Vaccines in the Clinical Development Table 11–10: Profectus BioSciences Promising Vaccines in the Clinical Development Table 11–11: Pneumagen Promising Vaccines in the Clinical Development Table 11–12: Themis Bioscience Promising Vaccines in the Clinical Development Table 11–13: Xeme Biopharma Promising Vaccines in the Clinical Development Table 11–14: Altimmune Vaccines Promising Vaccines in the Clinical Development Table 11–15: Pfenex Inc Promising Vaccines in the Clinical Development Table 11–16: Northwest Biotherapeutics Promising Vaccines in the Clinical Development Table 11–17: OncoBioMune Pharmaceuticals Promising Vaccines in the Clinical Development List of Figures: Figure 2–1: Global Vaccines Market Size (Million US$),2015 – 2018 Figure 2–2: Global Vaccines Market Size Forecast (Million US$),2019 – 2025 Figure 3–1: Global Vaccines Market Share, By Disease Indication (Percent),2018 Figure 3–2: Global Vaccines Market Share, By End User (Percent),2018 Figure 3–3: Global Vaccines Market Share by Brand (Percent), 2018 Figure 3–4: Global Vaccines Market Share by Company (Percent), 2018 Figure 5–1: Global Vaccines Market for Pneumococcal Disease (Million US$),2015 – 2018 Figure 5–2: Global Vaccines Market for Pneumococcal Disease Forecast (Million US$),2019 – 2025 Figure 5–3: Global Vaccines Market for DTP Disease (Million US$),2015 – 2018 Figure 5–4: Global Vaccines Market for DTP Disease Forecast (Million US$),2019 – 2025 Figure 5–5: Global Vaccines Market for Influenza Disease (Million US$),2015 – 2018 Figure 5–6: Global Vaccines Market for Influenza Disease Forecast (Million US$),2019 – 2025 Figure 5–7: Global Vaccines Market for HPV Disease (Million US$),2015 – 2018 Figure 5–8: Global Vaccines Market for HPV Disease Forecast (Million US$),2019 – 2025 Figure 5–9: Global Vaccines Market for Meningococcal Disease (Million US$),2015 – 2018 Figure 5–10: Global Vaccines Market for Meningococcal Disease Forecast (Million US$),2019 – 2025 Figure 5–11: Global Vaccines Market for Hepatitis Disease (Million US$),2015 – 2018 Figure 5–12: Global Vaccines Market for Hepatitis Disease Forecast (Million US$),2019 – 2025 Figure 5–13: Global Vaccines Market for MMR Disease (Million US$),2015 – 2018 Figure 5–14: Global Vaccines Market for MMR Disease Forecast (Million US$),2019 – 2025 Figure 5–15: Global Vaccines Market for Rotavirus Disease (Million US$),2015 – 2018 Figure 5–16: Global Vaccines Market for Rotavirus Disease Forecast (Million US$),2019 – 2025 Figure 5–17: Global Vaccines Market for Varicella Disease (Million US$),2015 – 2018 Figure 5–18: Global Vaccines Market for Varicella Disease Forecast (Million US$),2019 – 2025 Figure 5–19: Global Vaccines Market for Other Diseases (Million US$),2015 – 2018 Figure 5–20: Global Vaccines Market for Other Diseases Forecast (Million US$),2019 – 2025 Figure 6–1: Global Vaccines Market for Pediatric (Million US$),2015 – 2018 Figure 6–2: Global Vaccines Market for Pediatric Forecast (Million US$),2019 – 2025 Figure 6–3: Global Vaccines Market for Adult (Million US$),2015 – 2018 Figure 6–4: Global Vaccines Market for Adult Forecast (Million US$),2019 – 2025 Figure 7–1: GlobalPrevnar/Prevnar 13 Market Value (Million US$),2015–2018 Figure 7–2: Global Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025 Figure 7–3: GlobalGardasil/Gardasil 9 Market Value (Million US$),2015–2018 Figure 7–4: GlobalGardasil/Gardasil 9 Market Value Forecast (Million US$),2019–2025 Figure 7–5: Global Vaxigrip Market Value (Million US$),2015 – 2018 Figure 7–6: Global Vaxigrip Market Value Forecast (Million US$),2019 – 2025 Figure 7–7: Global Fluzone Market Value (Million US$),2015–2018 Figure 7–8: Global Fluzone Market Value Forecast (Million US$),2019–2025 Figure 7–9: Global Flublok Market Value & Forecast (Million US$),2018– 2025 Figure 7–10: Global Varivax Market Value (Million US$),2015–2018 Figure 7–11: Global Varivax Market Value Forecast (Million US$),2019–2025 Figure 7–12: Global Menactra Market Value (Million US$),2015–2018 Figure 7–13: Global Menactra Market Value Forecast (Million US$),2019–2025 Figure 7–14: Global Proquad Market Value (Million US$),2015–2018 Figure 7–15: Global Proquad Market Value Forecast (Million US$),2019–2025 Figure 7–16: Global Pneumovax 23 Market Value (Million US$),2015–2018 Figure 7–17: Global Pneumovax 23 Market Value Forecast (Million US$),2019–2025 Figure 7–18: Global Fluarix/FluLaval Market Value (Million US$),2015–2018 Figure 7–19: Global Fluarix/FluLaval Market Value Forecast (Million US$),2019–2025 Figure 7–20: Global Havrix/Twinrix/Engerix–B Market Value (Million US$),2015–2018 Figure 7–21: Global Havrix/Twinrix/Engerix–B Market Value Forecast (Million US$),2019–2025 Figure 7–22: Global Priorix, Priorix Tetra, Varilrix Market Value (Million US$),2015 – 2018 Figure 7–23: Global Priorix, Priorix Tetra, Varilrix Market Value Forecast (Million US$),2019 – 2025 Figure 7–24: Global M–M–R ll Market Value (Million US$),2015–2018 Figure 7–25: Global M–M–R ll Market Value Forecast (Million US$),2019–2025 Figure 7–26: Global Adacel Market Value (Million US$),2015–2017 Figure 7–27: Global Adacel Market Value Forecast (Million US$),2018–2025 Figure 7–28: Global Boostrix Market Value (Million US$),2015–2018 Figure 7–29: Global Boostrix Market Value Forecast (Million US$),2019–2025 Figure 7–30: Global Bexsero Market Value (Million US$),2015–2018 Figure 7–31: Global Bexsero Market Value Forecast (Million US$),2019–2025 Figure 7–32: Global Menveo Market Value (Million US$),2015–2018 Figure 7–33: Global Menveo Market Value Forecast (Million US$),2019–2025 Figure 7–34: Global Cervarix Market Value (Million US$),2015 – 2018 Figure 7–35: Global Cervarix Market Value Forecast (Million US$),2019 – 2025 Figure 7–36: Global Trumenba Market Value (Million US$),2016–2018 Figure 7–37: Global Trumenba Market Value Forecast (Million US$),2019–2025 Figure 7–38: Global Shingrix Market Value& Forecast (Million US$),2017–2018 Figure 7–39: Global Shingrix Market Value & Forecast (Million US$),2019 – 2025 Figure 7–40: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value (Million US$),2015–2018 Figure 7–41: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value Forecast (Million US$),2018 – 2025 Figure 7–42: Global Rotateq Market Value (Million US$),2015 – 2018 Figure 7–43: Global Rotateq Market Value Forecast (Million US$),2019 – 2025 Figure 7–44: Global Zostavax Market Value (Million US$),2015 – 2018 Figure 7–45: Global Zostavax Market Value Forecast (Million US$),2019 – 2025 Figure 7–46: Global Rotarix Market Value (Million US$),2015 – 2018 Figure 7–47: Global Rotarix Market Value Forecast (Million US$),2019 – 2025 Figure 7–48: Global Synflorix Market Value (Million US$),2015 – 2018 Figure 7–49: Global Synflorix Market Value Forecast (Million US$),2019 – 2025 Figure 7–50: Global Pediarix/Infanrix Market Value (Million US$),2015 – 2018 Figure 7–51: Global Pediarix/Infanrix Market Value Forecast (Million US$),2019 – 2025 Figure 7–52: Global Ticovac Market Value (Million US$),2015 – 2018 Figure 7–53: Global Ticovac Market Value Forecast (Million US$),2019 – 2025 Figure 7–54: Global Biken Ha Market Value (Million US$),2015 – 2018 Figure 7–55: Global Biken Ha Market Value Forecast (Million US$),2019– 2025 Figure 7–56: Global Tetrabik Market Value (Million US$),2015 – 2018 Figure 7–57: Global Tetrabik Market Value Forecast (Million US$),2019 – 2025 Figure 7–58: Global Mearubik Market Value (Million US$),2015 – 2018 Figure 7–59: Global Mearubik Market Value Forecast (Million US$),2019 – 2025 Figure 7–60: Global Varicella (MTP) Market Value (Million US$),2015 – 2018 Figure 7–61: Global Varicella (MTP) Market Value Forecast (Million US$),2019 – 2025 Figure 7–62: Global Jebik V Market Value (Million US$),2015 – 2018 Figure 7–63: Global Jebik V Market Value Forecast (Million US$),2019 – 2025 Figure 7–64: Global FluMist/Fluenz Market Value (Million US$),2015 – 2018 Figure 7–65: Global FluMist/Fluenz Market Value Forecast (Million US$),2019 – 2025 Figure 7–66: Global BioThrax Market Value (Million US$),2015 – 2018 Figure 7–67: Global BioThrax Market Value Forecast (Million US$),2019 – 2025 Figure 7–68: Global Dukoral Market Value (Million US$),2015 – 2018 Figure 7–69: Global Dukoral Market Value Forecast (Million US$),2019 – 2025 Figure 7–70: Global Ixiaro Market Value (Million US$),2015 – 2018 Figure 7–71: Global Ixiaro Market Value Forecast (Million US$),2019 – 2025 Figure 7–72: Global InLive Market Value (Million US$),2015 – 2018 Figure 7–73: Global InLive Market Value Forecast (Million US$),2019 – 2025 Figure 7–74: Global Healive Market Value (Million US$),2015 – 2018 Figure 7–75: Global Healive Market Value Forecast (Million US$),2019 – 2025 Figure 7–76: Global Bilive Market Value (Million US$),2015 – 2018 Figure 7–77: Global Bilive Market Value Forecast (Million US$),2019 – 2025 Figure 7–78: Global Anflu Market Value (Million US$),2015 – 2018 Figure 7–79: Global Anflu Market Value Forecast (Million US$),2019 – 2025 Figure 7–80: Global EasySix Market Value (Million US$),2015 – 2018 Figure 7–81: Global EasySix Market Value Forecast (Million US$),2019 – 2025 Figure 7–82: Global Imvamune Market Value (Million US$),2015 – 2018 Figure 7–83: Global Imvamune Market Value Forecast (Million US$),2019 – 2025 Figure 7–84: Global Other Vaccines Market Value (Million US$),2015 – 2018 Figure 7–85: Global Other Vaccines Market Value Forecast (Million US$),2019 – 2025 Figure 9–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–2: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2019 – 2025 Figure 9–3: GSK Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–4: GSK Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–5: Merck Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–6: Merck Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–7: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–8: Pfizer Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–9: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–10: AstraZeneca Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–11: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–12: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–13: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–14: Emergent Biosolutions Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–15: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–16: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–17: Valneva Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–18: Seqirus Vaccines Market Value Analysis (Million US$),2016 – 2018 Figure 9–19: Seqirus Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–20: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–21: Bavarian Nordic Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–22: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–23: Sinovac Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 9–24: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 9–25: Panacea Biotec Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025